LEVEL FOUR ADVISORY SERVICES, LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1696715
DALLAS, TX
Position in VRTX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$4,252,846
-$78,102 QoQ
Shares Held
9,524
-0.3% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
20 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026LEVEL FOUR ADVISORY SERVICES, LLC holds $8,781,235 across 9 Biotechnology names. VRTX ranks #1 (48.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
9,524 | $4,252,846 | |
| 2 | GMAB |
Genmab A/S
|
57,023 | $1,529,927 | |
| 3 | ARGX |
Argenx SE
|
1,131 | $825,912 | |
| 4 | CELC |
Celcuity Inc.
|
6,417 | $732,436 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
895 | $691,512 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
3,471 | $656,192 | |
| 7 | MNKD |
Mannkind Corp
|
21,098 | $51,690 | |
| 8 | OCGN |
Ocugen, Inc.
|
17,000 | $30,770 |
All Filings in VRTX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,252,846 | 9,524 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $4,330,948 | 9,553 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,970,981 | 7,586 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $3,317,185 | 7,451 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $4,089,941 | 8,436 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $3,006,960 | 7,467 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $3,270,907 | 7,033 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $3,363,066 | 7,175 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $3,145,107 | 7,524 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $2,960,531 | 7,276 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $2,631,000 | 7,566 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,650,234 | 7,531 | Shares | Sole | 2023-07-10 | |
| 2023-03-31 | $2,361,764 | 7,496 | Shares | Sole | 2023-06-05 | |
| 2022-12-31 | $2,284,538 | 7,911 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $2,498,730 | 8,630 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $2,505,676 | 8,892 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $2,430,674 | 9,314 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $2,026,249 | 9,227 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,778,166 | 9,803 | Shares | Sole | 2021-10-12 | |
| 2020-06-30 | $251,118 | 865 | Shares | Sole | 2020-08-17 | |
| No filing history on record for this holder in this stock. | ||||||